MohammedAAshrafMD

PubMed

• 3 citations
  Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage.
  Ahmad M. Mansour, Mohammed Ashraf, Khalil M El Jawhari, Michel Eid Farah, Ahmed Souka, Chintan Sarvaiya, Sumit Randhir Singh, Alay S. Banker, Jay Chhablani> ;International Journal of Retina and Vitreous. 2020 Jan 14
• 26 citations
  MULTILEVEL ISCHEMIA IN DISORGANIZATION OF THE RETINAL INNER LAYERS ON PROJECTION-RESOLVED OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY
  Alex C. Onishi, Mohammed Ashraf, Brian T. Soetikno, Amani A. Fawzi> ;Retina. 2019 Aug 1
• 1 citations
  "For Mass Eye and Ear Special Issue" Adaptive Optics in the Evaluation of Diabetic Retinopathy.
  Omar Abdelal, Mohammed Ashraf, Konstantina Sampani, Jennifer K. Sun> ;Seminars in Ophthalmology. 2019 Jun 12
• 25 citations
  Safety of 5914 intravitreal ziv-aflibercept injections.
  Sumit Randhir Singh, Michael W. Stewart, Goura Chattannavar, Mohammed Ashraf, Ahmed Souka, Mazen ElDardeery, Neeraj Wadhwa, Chintan Sarvaiya, Ahmad M. Mansour, Ameen M...> ;The British Journal of Ophthalmology. 2019 Jun 1
• Cambio a ranibizumab en edema macular diabético refractario al tratamiento con bevacizumab
  Mohamed Ashraf, Ahmed Souka, M. Daich Varela, H. el Kayal, P.G. Schlottmann> ;Archivos De La Sociedad Espanola De Oftalmologia. 2018 Nov 1
• 60 citations
  Statistical Model of Optical Coherence Tomography Angiography Parameters That Correlate With Severity of Diabetic Retinopathy.
  Mohammed Ashraf, Peter L. Nesper, Lee M. Jampol, Fei Yu, Amani A. Fawzi> ;Investigative Ophthalmology & Visual Science. 2018 Aug 1
• 51 citations
  Age-related macular degeneration: using morphological predictors to modify current treatment protocols.
  Mohammed Ashraf, Ahmed Souka, Ron A. Adelman> ;Acta Ophthalmologica. 2018 Mar 1
• 4 citations
  Switching Anti-Vascular Endothelial Growth Factors in Refractory Neovascular Age-Related Macular Degeneration.
  Mohammed Ashraf, Touka Banaee, Fabiana Q. Silva, Rishi P Singh> ;Ophthalmic Surgery, Lasers & Imaging Retina. 2018 Mar 1
• 25 citations
  Two-year outcomes of intravitreal ziv-aflibercept
  Ahmad M. Mansour, Mohammed Ashraf, Abdulrazzak Charbaji, Muhammad H Younis, Ahmed Souka, Avantika Dogra, Hana A Mansour, Jay Chhablani> ;The British Journal of Ophthalmology. 2018 Jan 9
• 14 citations
  Long-term safety and efficacy of ziv-aflibercept in retinal diseases
  Ahmad M. Mansour, Mohammed Ashraf, Chintan J Dedhia, Abdulrazzak Charbaji, Ahmed Souka, Jay Chhablani> ;The British Journal of Ophthalmology. 2017 Oct 1
• 15 citations
  Switching Anti-VEGF Drugs in the Treatment of Diabetic Macular Edema
  Touka Banaee, Mohammed Ashraf, Felipe F Conti, Rishi P Singh> ;Ophthalmic Surgery, Lasers & Imaging Retina. 2017 Sep 1
• 1 citations
  ASSOCIATION BETWEEN THE VITREOMACULAR INTERFACE AND OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS IN WET AGE-RELATED MACULAR DEGENERATION.
  Mohammed Ashraf, Ahmed Souka, Ron A. Adelman> ;Retina. 2017 Sep 1
• 17 citations
  Optical Coherence Tomography Angiography: Potential Artifacts in Acute Macular Neuroretinopathy.
  Mohammed Ashraf, Debra A. Goldstein, Amani A. Fawzi> ;JAMA Ophthalmology. 2017 Jun 1
• 16 citations
  Aflibercept in age-related macular degeneration: evaluating its role as a primary therapeutic option.
  Mohammed Ashraf, Ahmed Souka> ;Eye. 2017 May 26
• 14 citations
  Safety and Efficacy of Ziv-Aflibercept in the Treatment of Refractory Diabetic Macular Edema.
  Mohammed Ashraf, Hassan El Kayal, Ahmed Souka> ;Ophthalmic Surgery, Lasers & Imaging Retina. 2017 May 1
• 22 citations
  Short-Term Effects of Early Switching to Ranibizumab or Aflibercept in Diabetic Macular Edema Cases With Non-Response to Bevacizumab.
  Mohammed Ashraf, Ahmed Souka, Hassan Elkayal> ;Ophthalmic Surgery, Lasers & Imaging Retina. 2017 Mar 1
• 2 citations
  Functional and Anatomic Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab.
  Mohammed Ashraf> ;Investigative Ophthalmology & Visual Science. 2017 Mar 1
• 1 citations
  Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option.
  M Ashraf, A Souka, R Adelman, S H Forster> ;Eye. 2017 Feb 1
• 9 citations
  Comparison between the short-term outcomes of bevacizumab and ziv-aflibercept in the treatment of primary diabetic macular oedema.
  Mohammed Ashraf, Hassan El Kayal, Ahmed Souka> ;Acta Ophthalmologica. 2017 Dec 1
• 5 citations
  Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option.
  M Ashraf, A Souka, R Adelman, S H Forster> ;Eye. 2016 Dec 1
• 56 citations
  Predicting outcomes to anti-vascular endothelial growth factor (VEGF) therapy in diabetic macular oedema: a review of the literature
  Mohammed Ashraf, Ahmed Souka, Ron A. Adelman> ;The British Journal of Ophthalmology. 2016 May 26
• 11 citations
  Three-month outcomes of ziv-aflibercept in the treatment of diabetic macular oedema
  Mohammed Ashraf, Ahmed Souka, Hassan El Kayal, Mostafa M El Manhaly, Mohamed Hossam Abdallah> ;Acta Ophthalmologica. 2016 May 26
• Response to: 'Comment on Central retinal vein occlusion: modifying current treatment protocols'.
  Mohammed Ashraf, Ahmed Souka, Rishi P Singh> ;Eye. 2016 Apr 22
• 34 citations
  Central retinal vein occlusion: modifying current treatment protocols
  Mohammed Ashraf, Ahmed Souka, Rishi P Singh> ;Eye. 2016 Feb 12
• 6 citations
  Steroids in Central Retinal Vein Occlusion: Is There a Role in Current Treatment Practice?
  Mohammed Ashraf, Ahmed Souka> ;Journal of Ophthalmology. 2015 Oct 8
• Join now to see all